International Journal of Clinical Research

Objective To analyze the clinical effects of atorvastatin and rosuvastatin respectively in the treatment of coronary heart disease. Methods A total of 106 patients with coronary heart disease (from January 2023 to January 2024) were selected from our hospital and divided into 2 groups with 53 cases in each group. Both groups received conventional basic treatment, while the control group was given atorvastatin and the observation group was given rosuvastatin. The clinical effect, heart function and blood lipid indexes of the two groups were evaluated. Results The total effective rate of the observation group was higher than that of the control group (P < 0.05). After treatment, the left ventricular ejection fraction (LVEF) and cardiac output (CO) of the observation group were higher than those of the control group, and the differences were statistically significant (P < 0.05). After treatment, triglyceride (TG) and total cholesterol (TC) in the observation group were decreased compared with that in the control group, and there were differences in statistical analysis (P < 0.05). Conclusion Rosuvastatin has better clinical effect than atorvastatin in the treatment of coronary heart disease, which can effectively reduce blood lipids and promote the improvement of cardiac function.

Coronary heart disease; Atorvastatin; Rosuvastatin; Blood lipids, heart function